University of Texas Southwestern Medical Center - Accepting Juvenile Patients, Dallas
Houston Methodist Hospital - Accepting Adult Patients, Houston
University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston

În curs de recrutareFaza 2/3

Vârste de la 6 la 75 · Toate sexele · Actualizat 17 sept. 2026 · NCT06154252

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

University of Texas - Houston, Houston

În curs de recrutareFaza 2

Vârste de 18 ani și peste · Toate sexele · Actualizat 17 sept. 2026 · NCT07103746

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Baylor College of Medicine, Houston

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 9 sept. 2026 · NCT06948318

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

GSK Investigational Site, Houston
GSK Investigational Site, Temple

În curs de recrutareFaza 3

Vârste de 18 ani și peste · Toate sexele · Actualizat 8 sept. 2026 · NCT06572384

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

University of Texas MD Anderson Cancer Center, Houston

În curs de recrutareFaza 1/2

Vârste de la 18 la 65 · Toate sexele · Actualizat 26 aug. 2026 · NCT06121297

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Dallas Renal Group, Dallas
Dallas Renal Group, Dallas
Nephro Asso North Illinois Indiana, Houston

În curs de recrutareFaza 3

Vârste de la 18 la 100 · Toate sexele · Actualizat 17 aug. 2026 · NCT06858319

Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study

University of Texas at Austin, Austin

În curs de recrutare

Vârste de la 18 la 80 · Toate sexele · Actualizat 17 aug. 2026 · NCT07759115

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Baylor College of Medicine Neurology Department, Houston
Houston Methodist Hospital, Houston
University of Texas MD Anderson Cancer Center, Houston

În curs de recrutareFaza 1/2

Vârste de la 18 la 70 · Toate sexele · Actualizat 13 aug. 2026 · NCT06359041

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

UT Southwestern Medical Center, Dallas
Cook Children's Medical Center, Fort Worth
Texas Children's Hospital/ Baylor College of Medicine, Houston
și încă 1

În curs de recrutareFaza 3

Vârste de 12 ani și peste · Toate sexele · Actualizat 6 aug. 2026 · NCT06056297

Study of BHV-1300 in Graves' Disease

Site-109, Dallas
Site-106, Houston
Site-101, Houston
și încă 1

În curs de recrutareFaza 1

Vârste de la 18 la 65 · Toate sexele · Actualizat 31 iul. 2026 · NCT06980649

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Site Number - 1003, Dallas
Site Number - 1047, Denton
Site Number - 1057, Houston
și încă 1

În curs de recrutareFaza 3

Vârste de la 18 la 80 · Toate sexele · Actualizat 30 iul. 2026 · NCT07039916

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Houston Methodist Hospital, Houston

În curs de recrutareFaza 2/3

Vârste de la 18 la 75 · Toate sexele · Actualizat 29 iul. 2026 · NCT06193889

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Medical City Dallas, Dallas
Children's Medical Center Dallas, Dallas
Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
și încă 5

În curs de recrutareStudiu observațional

Toate vârstele · Toate sexele · Actualizat 6 iul. 2026 · NCT01351545

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

UT Southwestern Medical Center, Dept. of Dermatology, Dallas
MD Anderson Texas Medical Center, Houston

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 29 mai 2026 · NCT04422912

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M D Anderson Cancer Center, Houston

În curs de recrutareStudiu observațional

Vârste de 18 ani și peste · Toate sexele · Actualizat 20 mai 2026 · NCT04751396

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

MD Anderson Cancer Center, Houston
The University of Texas Health Science Center at Houston, Houston

În curs de recrutareFaza 1/2

Vârste de 18 ani și peste · Toate sexele · Actualizat 15 apr. 2026 · NCT06434363

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

UT Southwestern Medical Center, Dallas
Houston Methodist Hospital, Houston

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 25 feb. 2026 · NCT06626919

Sursă: ClinicalTrials.gov, date preluate la 4 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.